SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

As part of a licensing agreement inked early this year, the French drugmaker will market Nuvaxovid during the 2025-2026 vaccination season in the U.S., Europe, and several major markets.

The European Medical Agency (EMA) had greenlighted the immunizer, which is traded under the brand Nuvaxovid, earlier this week. The drug's developers trust this new medication, developed following ...

Dr Clive Dix said that Nuvaxovid has excellent clinical data and – as a it has good stability at fridge temperatures – could be easily rolled out with the flu vaccine next winter, and should ...

With Sanofi (SNY) expected to join the company’s commercialization efforts in 2025, many issues Novavax (NVAX) encountered with the rollout of its COVID-19 shot, Nuvaxovid, in the 2023–24 ...